Celgene (CELG)

Company Description

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation.

 

COMPANY ADDRESS
86 Morris Avenue
Summit, NJ 07901
United States

COMPANY PHONE
908-673-9000

COMPANY WEBSITE



Get BioInvest's perspective on Celgene's CEO


Latest Company News

Buy, Sell or Hold? Analysts Approach: Harley-Davidson, Inc. (HOG), Celgene ... The USA Commerce - 4 hours ago Shares of Harley-Davidson, Inc. (NYSE:HOG) surged 0.91% to $56.32. During the trading on 04/24/2017, Company's stock ranged from $56.97 to $56.12. 2 Stocks Reach Important Points: Harley-Davidson, Inc. (HOG), Celgene ... - W News [...]
Tue, Apr 25, 2017 2:48:00 PM, Continue reading at the source
Better Buy: Celgene Corporation vs. Merck & Co., Inc. Bloomington Pantagraph - 7 hours ago Two of the hottest cancer drugs around belong to Celgene Corporation (NASDAQ: CELG) and Merck & Co., Inc. (NYSE: MRK). Celgene claims blockbuster blood cancer drug Revlimid, while Merck's Keytruda appears to be one of the most powerful lung ... The Technical Chart For Celgene Corporation (CELG) Is Speaking Volumes - NY Stock News Celgene (CELG) to Post Q1 Earnings: What's in the Cards? - Yahoo Finance [...]
Tue, Apr 25, 2017 12:23:00 PM, Continue reading at the source
Analytical Guide for two rising stock's: Wynn Resorts, Limited (WYNN), Celgene ... StockNewsJournal - Apr 24, 2017 Wynn Resorts, Limited (NASDAQ:WYNN) market capitalization at present is $11.69B at the rate of $115.90 a share. The firm's price-to-sales ratio was noted 2.64 in contrast with an overall industry average of 3.38. [...]
Mon, Apr 24, 2017 7:18:00 PM, Continue reading at the source
What Celgene Corporation (CELG) And Its Chart Reveal Today NY Stock News - Apr 24, 2017 The technicals for Celgene Corporation (CELG) have taken shape, and with them a comprehensive picture has emerged. This is the current state of play as presented by the current technical setup. [...]
Mon, Apr 24, 2017 4:52:00 PM, Continue reading at the source
Analytical Guide for Retail Properties of America, Inc. (RPAI), Celgene ... The USA Commerce - Apr 24, 2017 Shares of Retail Properties of America, Inc. (NYSE:RPAI) dropped -0.82% to $14.52. During the trading on 04/21/2017, Company's stock ranged from $14.65 to $14.45. [...]
Mon, Apr 24, 2017 3:11:00 PM, Continue reading at the source
Celgene: The Next Dominant Pharma Company Seeking Alpha - Apr 19, 2017 Celgene's 4 best-selling drugs are all patent-protected in the U.S. until at least 2024, which provides de-risked long-term growth potential. These two stocks are dominating the market, As Expected: Celgene Corporation ... - StockNewsJournal Celgene Corporation (NASDAQ:CELG) is expanding its presence in Cambridge - Benchmark Monitor [...]
Wed, Apr 19, 2017 9:11:00 PM, Continue reading at the source
Celgene Stock History: The Biotech's Path to Gigantic Gains Motley Fool - Apr 14, 2017 A quick analysis of Celgene Corporation (NASDAQ:CELG) stock history reveals three distinct stages with four stock splits along the way. [...]
Fri, Apr 14, 2017 6:33:00 PM, Continue reading at the source
Why Celgene Corporation (NASDAQ:CELG) Stock Looks Ready to Breakout BNL Finance (press release) (registration) (blog) - Apr 3, 2017 For the past two and a half years, CELG stock has been mostly dead money. This despite Celgene Corporation (NASDAQ:CELG) having a pipeline of blockbusters and rapid existing growth. Celgene (CELG) Gets Paragraph IV Notice Letter for Pomalyst - Yahoo Finance Does Celgene Corporation's (CELG) share price already account for its high growth? - Simply Wall St [...]
Mon, Apr 03, 2017 8:27:00 PM, Continue reading at the source
Better Buy: Celgene Corporation vs. Amgen Inc. Motley Fool - Apr 1, 2017 Celgene (NASDAQ:CELG) and Amgen (NASDAQ:AMGN) definitely belong in that category. In the last five years, Celgene's share price has more than tripled, while Amgen stock is up over 140%. But which of these biotech stocks is the better buy for investors ... [...]
Sat, Apr 01, 2017 3:33:00 PM, Continue reading at the source
Better Buy: Celgene Corporation vs. Gilead Sciences Motley Fool - Mar 27, 2017 In one corner stands Celgene Corporation (NASDAQ:CELG), an oncology powerhouse on the rise. In the other corner stands Gilead Sciences, Inc. (NASDAQ:GILD), an antiviral heavyweight that may be past its prime. [...]
Mon, Mar 27, 2017 1:41:00 PM, Continue reading at the source